Scientists tested the cytotoxicity of novel azulene hydrazide-hydrazone-based chelators against pancreatic cancer cell lines (MIA PaCa-2, PANC-1, AsPC-1).
[Biomedicine & Pharmacotherapy]
Azulene Hydrazide-Hydrazones for Selective Targeting of Pancreatic Cancer Cells
